Transcriptomic profiling revealed that PDGCOs_1 expressed elevated levels of tumor epithelial and stem cell markers, such as EPCAM, CDH1, ALDH3A1, CA9, CD24, and CD133 (Figure 3c). This evidence concerns the gene EPCAM and neoplasm.